Dropouts in sublingual allergen immunotherapy trials – a systematic review
Open Access
Abstract
Participant dropouts can reduce the power of allergen immunotherapy clinical trials. Evaluation of the dropout rate and reasons for dropout are important not only in the planning of clinical studies but are also relevant for adherence to immunotherapy in daily clinical practice. A systematic review was carried out in order to establish the overall dropout rate among published double‐blind, placebo‐controlled randomized clinical trials of sublingual immunotherapy for respiratory allergic diseases. Dropouts were analysed in regards to allergen, formulation, treatment schedule, participant age, study size, number of centres and type of allergic disease. Relative dropout rates in placebo and active groups as well as reasons for dropout were also assessed. A total of 81 studies, comprising 9998 patients, were included. Dropout rates in sublingual immunotherapy controlled studies do not appear to be a major problem with a composite dropout percentage of 14% (95% CI:11.9–16). Furthermore, they are not different for active compared to placebo‐treated participants. This lends support to the positive clinical outcomes seen in meta‐analyses of these trials.Keywords
This publication has 82 references indexed in Scilit:
- Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: A double-blind-placebo-controlled randomised trialRespiratory Medicine, 2013
- Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen–induced rhinoconjunctivitisJournal of Allergy and Clinical Immunology, 2011
- Effectiveness of high dose sublingual immunotherapy to induce a stepdown of seasonal asthma: a pilot studyCurrent Medical Research and Opinion, 2009
- Does asthma control correlate with quality of life related to upper and lower airways? A real life studyAllergy, 2009
- Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitisAnnals of Allergy, Asthma & Immunology, 2004
- Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double‐blind placebo‐controlled studyAllergy, 2004
- Knowledge and expectations of patients receiving aeroallergen immunotherapyAnnals of Allergy, Asthma & Immunology, 2003
- Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial☆☆☆★Journal of Allergy and Clinical Immunology, 1999
- Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma—a placebo controlled studyAnnals of Allergy, Asthma & Immunology, 1999
- Patient dropouts before completion of optimal dose, multiple allergen immunotherapyAnnals of Allergy, Asthma & Immunology, 1999